Effect of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis

Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. PARTNER Trial Investigators, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232 Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616 Tokarek, 2015, Clinical outcomes in patients after surgical and transcatheter aortic valve replacement, Pol Arch Med Wewn, 10, 755 Bagienski, 2016, Early and mid-term outcomes after transcatheter aortic valve implantation. Data from a single center registry, Adv Interv Cardiol, 12, 122, 10.5114/aic.2016.59362 Kleczyński, 2014, Short- and intermediate-term improvement of patient quality of life after transcatheter aortic valve implantation: a single-center study, Kardiol Pol, 72, 612, 10.5603/KP.a2014.0065 Kleczyński, 2016, Twelve-month quality of life improvement and all-cause mortality in elderly patients undergoing transcatheter aortic valve replacement, Int J Artif Organs, 39, 444, 10.5301/ijao.5000521 Tokarek, 2016, Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement, Catheter Cardiovasc Interv, 88, 80, 10.1002/ccd.26400 Stokłosa, 2015, The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness – single-centre experience, Adv Interv Cardiol, 11, 37, 10.5114/pwki.2015.49183 Anderson, 1994, First publications from the society of thoracic surgeons National Database, Ann Thorac Surg, 57, 6, 10.1016/0003-4975(94)90355-7 Nashef, 1999, European system for cardiac operative risk evaluation (EuroSCORE), Eur J Cardiothorac Surg, 16, 9, 10.1016/S1010-7940(99)00134-7 Nakamura, 2016, Diabetes mellitus impairs left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis, Heart Lung Circ, 25, 68, 10.1016/j.hlc.2015.05.019 Chorin, 2015, Impact of diabetes mellitus and hemoglobin A1C on Outcome after transcatheter aortic valve implantation, Am J Cardiol, 116, 1898, 10.1016/j.amjcard.2015.09.032 Conrotto, 2014, Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry), Am J Cardiol, 113, 529, 10.1016/j.amjcard.2013.10.025 Puls, 2014, Diabetes increases short- and long-term mortality after transcatheter aortic valve implantation (TAVI), Dtsch Med Wochenschr, 139, 822 Berkovitch, 2015, Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement, Cardiovasc Diabetol, 14, 131, 10.1186/s12933-015-0291-3 Minha, 2015, The impact of diabetes mellitus on outcome of patients undergoing transcatheter aortic valve replacement, IJC Metab Endocr, 9, 54, 10.1016/j.ijcme.2015.05.023 Foussas, 2016, Acute coronary syndromes and diabetes mellitus, Hell J Cardiol, 57, 375, 10.1016/j.hjc.2016.12.012 Tamburino, 2011, Incidence and predictors of early and late mortality after transcatheter aortic Valle implantation in 663 patients with severe aortic stenosis, Circulation, 123, 299, 10.1161/CIRCULATIONAHA.110.946533 Muñoz-García, 2013, Ibero-American registry investigators. The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results, Int J Cardiol, 169, 359, 10.1016/j.ijcard.2013.09.006 Abramowitz, 2016, Impact of diabetes mellitus on outcomes after transcatheter aortic valve implantation, Am J Cardiol, 117, 1636, 10.1016/j.amjcard.2016.02.040 Boudoulas, 2017, The role of interventional cardiology to our understanding of basic mechanisms related to coronary atherosclerosis: “thinking outside the box”, Hell J Cardiol, 58, 110, 10.1016/j.hjc.2016.10.002 Kleczyński, 2017, Impact of frailty on mortality after transcatheter aortic valve implantation, Am Heart J, 185, 52, 10.1016/j.ahj.2016.12.005 Kappetein, 2012, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, EuroIntervention, 8, 782, 10.4244/EIJV8I7A121 2016, 2016 Guidelines on the management of diabetic patients. A position of Diabetes Poland, Clin Diabetol, 5, 1 Capodanno, 2014, OBSERVANT Research Group. A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement, Am J Cardiol, 113, 1851, 10.1016/j.amjcard.2014.03.014 Ludman, 2015, Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012, Circulation, 131, 1181, 10.1161/CIRCULATIONAHA.114.013947 Sun, 2017, Meta-analysis of impact of diabetes mellitus on outcomes after transcatheter aortic valve implantation, Am J Cardiol, 119, 623, 10.1016/j.amjcard.2016.10.048 Généreux, 2012, Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, J Am Coll Cardiol, 60, 1043, 10.1016/j.jacc.2012.07.003 Falcão-Pires, 2011, Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness, Circulation, 124, 1151, 10.1161/CIRCULATIONAHA.111.025270 Bagienski, 2017, Sex-related differences in clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic stenosis, Adv Interv Cardiol, 10.5114/aic.2017.70195 Kleczynski, 2016, Long-term mortality and quality of life after transcatheter aortic valve insertion in very elderly patients, J Invasive Cardiol, 28, 492 Castro-Rodríguez, 2016, Frailty as a major factor in the increased risk of death and disability in older people with diabetes, J Am Med Dir Assoc, 17, 949, 10.1016/j.jamda.2016.07.013